Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,767.60
(
-1.51%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
108.48
(
1.78%
)
Bitcoin
70,769.13
(
-0.66%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Regulardoc post# 119633

Sunday, 05/08/2011 4:08:19 PM

Sunday, May 08, 2011 4:08:19 PM

Post# of 257257
Lovenox in VTE prevention: The 2009 WSJ article in #msg-38689726 is on-point (as is xrymd’s reply in #msg-38690733). From an investment standpoint, the question is whether the newfound emphasis on averting DVT/PE amounts to material incremental sales or is merely roundoff error in the overall scheme of things.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now